The cannabis compound cannabidiol (CBD) interacts strongly with several proteins tied to breast cancer growth and spread, highlighting its potential as a multi-target treatment candidate, according to ...

A study published in Cancer Letters by researchers from the University of Louisville found that a specially designed oral CBD formulation significantly improved tumor targeting and slowed the growth ...

The "Exosome Diagnostic and Therapeutics Market - Growth, Share, Opportunities & Competitive Analysis, 2025 - 2032" report has been added to the Credence ...

Walk into a Miami med spa and leave with “brighter, more even skin tone” delivered via exosome microneedle injections in your face. Or visit a Winter Haven med spa and get ...

March 4, 2026 / BrYet US, Inc. ("BrYet") - a biotechnology innovator focused on developing curative therapies for advanced cancers - announced today that it has filed an Investigational New Drug (IND) ...

BrYet US, Inc. (“BrYet”) — a biotechnology innovator focused on developing curative therapies for advanced cancers — ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% of triple-negative breast cancer (TNBC) and lung cancer cells within 96 ...

The final, formatted version of the article will be published soon. Globally, lung cancer ranks as the second most prevalent type of cancer and stands as the primary cause of cancer-related fatalities ...

NEW YORK – MDxHealth executives on Tuesday said the company is acquiring Bio-Techne's Exosome Diagnostics business for $15 million, describing the deal as "transformative" with the potential to ...